ER 50891 (quarterhydrate)

Produktübersicht

• Artikelname: ER 50891 (quarterhydrate)
• Artikelnummer: MCE-HY-108531A
• Hersteller Artikelnummer: HY-108531A
• Alternativnummer: MCE-HY-108531A-10MG,MCE-HY-108531A-5MG,MCE-HY-108531A-1MG,MCE-HY-108531A-50MG,MCE-HY-108531A-100MG,MCE-HY-108531A-25MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

ER 50891 quarterhydrate is a RARalpha antagonist. ER 50891 can significantly antagonize the inhibitory effect of all-trans retinoic acid (ATRA) on the total cell metabolic activity and proliferation of MC3T3-E1 preosteoblasts. ER 50891 rescues ATRA-inhibited osteocalcin (OCN) expression and extracellular matrix mineralization, and suppresses alkaline phosphatase (ALP) activity synergistically. ER 50891 can be used for the study of osteoporosis related to ATRA-induced inhibition of osteoblastogenesis[1].

Produkteigenschaften

• Molekulargewicht: 437.02
• Reinheit: 99.86
• Formel: C29H24N2O2.1/4H20
• Target-Kategorie: RAR/RXR

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound